Pascal Raymond Georges Poignard
Inventor
Stats
- 5 US patents issued
- 16 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 16 US Applications Filed
- 90 Total Citation Count
- Jun 5, 2024 Most Recent Filing
- Mar 17, 2010 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2
2 | 2013
2016 |
THERACLONE SCIENCES, INC. | 2
2 2 1 1 | 2010
2013 2015 2016 2017 |
INTERNATIONAL AIDS VACCINE INITIATIVE | 2
4 2 3 1 | 2010
2013 2015 2016 2017 |
The Scripps Research Institute | 2
4 2 3 1 | 2010
2013 2015 2016 2017 |
Inventor Addresses
Address | Duration |
---|---|
San Diego, CA, US | Feb 24, 11 - Oct 17, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 16 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0343,782 | 2024 | MONOCLONAL ANTIBODIES DIRECTED AGAINST TRIMERIC FORMS OF THE HIV-1 ENVELOPE GLYCOPROTEIN WITH BROAD AND POTENT NEUTRALIZING ACTIVITY | 0 |
12018067 | 2024 | Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity | 0 |
2024/0132,578 | 2024 | METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES | 0 |
11845789 | 2023 | Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies | 0 |
2023/0295,278 | 2023 | MONOCLONAL ANTIBODIES DIRECTED AGAINST TRIMERIC FORMS OF THE HIV-1 ENVELOPE GLYCOPROTEIN WITH BROAD AND POTENT NEUTRALIZING ACTIVITY | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.